Impact of pharmaceutical industry agglomeration on total factor productivityLIU Bo-yan, LU Cheng-kun, CHU Shu-zhen852-857
Features analysis and management strategies for non-compliance/violation in bioequivalence studiesZHOU Yun-ao, TIAN Xiao-hua, HAO Xiao-hua, YANG Zhi-yun, JIA Wang-yan, WU Guo-an858-863
Considerations on quality and efficacy consistency evaluation and volume-based procurement of chemical drug injectionsCHEN Hao, RAO Yuan-hong864-868
The enlightenment of French generic drugs substitution plan to ChinaWAN Chu-chuan, LU Meng-qing, XU Ai-lin, XI Xiao-yu869-874
Considerations on the research and development and consistency evaluation of generic peptide pharmaceuticalsHU Yu-xi, HAN Tian-jiao, HU Yan-chen875-880
Applications and challenges of 3D printing technology in oral solid dosage formsWANG Sen-yi, LI Si-jia, TU Ying-ying, LI Ling-hui, JIANG Shu-guang881-889
Research progress in cardiovascular pharmacological effect and mechanism of garlic and its active ingredientsCUI Tian-wei, LI Yi-kui, ZHANG Jin-yan890-894
Clinical observation of Gulong capsules combined with DMARDs in treating rheumatoid arthritisTANG Xiao-po, JIANG Quan, LIU Ying, HUANG Chuan-bing, LIU Pin-li, YAN Xiao-ping, BAI Yun-jing, SHEN Hong-bo895-902
The application of conditional power in the clinical trials of vaccinesTONG Liang, JIANG Zhi-wei, LI Chen, LI Fan, GE Wei, HU Hai-xia, WANG Ling, XIA Jie-lai903-907